IP Library Granted Patent US 10,159,795
Granted Patent B2
US 10,159,795 · App. 14/763,868 · Granted Dec 25, 2018

Drug delivery device

Inventor: George Cave (Warwickshire, GB)
Assignee: Sanofi-Aventis Deutschland GMBH
A61M5/3134A61M5/20A61M5/34A61M5/345A61M5/347A61M5/24A61M2005/206A61M2205/50A61M2205/502A61M2205/8237A61M2205/8262
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,159,795
App. No.
14/763,868
Granted
Dec 25, 2018
Kind
B2
Abstract

A drug delivery device for administering a drug is presented having a body adapted to retain a cartridge containing a drug, at least one electrical unit and a port for electrically contacting the electrical unit, an adapter for attaching an injection needle to the drug delivery device, a safety mechanism arranged to prevent access to the port while an injection needle is in fluid communication with the cartridge and arranged to prevent establishing a fluid communication between an injection needle and the cartridge while the port is accessible.

Claims (20)

1. A drug delivery device for administering a drug, comprising:

a body adapted to retain a cartridge containing a drug;

an electrical unit;

a port for electrically contacting the electrical unit;

an adapter for attaching an injection needle to the drug delivery device, wherein the adaptor has a first part and a second part; and

a safety mechanism arranged to prevent access to the port whilst the injection needle is in fluid communication with the cartridge and arranged to prevent establishing a fluid communication between the injection needle and the cartridge whilst the port is accessible,

wherein the body comprises a main component comprising the first part of the adaptor and a movable body component comprising the second part of the adapter, wherein the movable body component is movable relative to the main component between a misaligned position, in which the port is accessible and an aligned position in which the port is covered, wherein when the movable body component is in the misaligned position, the first part and the second part are not aligned and the injection needle is prevented from attachment of the injection needle to the adapter, wherein movement of the movable body component from the aligned position into the misaligned position is prevented when the first part and the second part are aligned and the injection needle is attached to the adapter.

2. The drug delivery device according to claim 1 , wherein in the aligned position, the port is hidden by the movable body component or by a sliding door coupled to the movable body component.

3. The drug delivery device according to claim 2 , wherein the sliding door is coupled to the movable body component through a linkage.

4. The drug delivery device according to claim 2 , wherein a retaining pin coupled to the sliding door and biased towards the movable body component is arranged to be engaged by the movable body component in the aligned position and disengaged in the misaligned position.

5. The drug delivery device according to claim 1 , wherein the movable body component is arranged to translate and/or rotate between the aligned position and the misaligned position.

6. The drug delivery device according to claim 5 , wherein the translation of the movable body component comprises an axial component and/or a radial component.

7. The drug delivery device according to claim 5 , wherein the movable body component is arranged to rotate about a pivot point or a hinge defining a pivot axis having a longitudinal and/or a transversal direction component.

8. The drug delivery device according to claim 1 , wherein the movable body component is detachable from the main component in the misaligned position.

9. The drug delivery device according to claim 1 , wherein the movable body component encompasses the second part of the adapter, wherein the second part of the adapter is substantially a quarter sector of the adapter.

10. The drug delivery device according to claim 1 , wherein an inner surface of the movable body component is formed to define two edges, one of the two edges radially supports the cartridge when the movable body component is in the aligned position and the other of the two edges radially supports the cartridge when the movable body component is in the misaligned position.

11. The drug delivery device according to claim 10 , wherein the two edges are defined by a number of circumferential ribs formed within the movable body component.

12. The drug delivery device according to claim 1 , wherein the adapter comprises a threaded area for engaging a threaded needle hub of the injection needle.

13. The drug delivery device according to claim 1 , wherein a spring is arranged for biasing the movable body component towards the aligned position or towards the misaligned position.

14. The drug delivery device according to claim 1 , wherein the movable body component and the main component are arranged to form a slide restraint, wherein the slide restraint is arranged for limiting movement of the movable body component.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 14, 2015
From: CAVE, GEORGE
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 036558/0987 →
Priority Claims (1)
EP 13153140 · Jan 29, 2013 · regional
Continuity (1)
Related Publication 20150367075A1 · Dec 24, 2015
Cited By (13)
US 1,065,512 US 1,071,156 US 1,071,160 US 1,071,163 US 1,072,240 US 1,073,061 US 1,083,087 US 1,084,306 US 1,095,819 US 1,097,129 US 1,106,445 US 1,123,151 US 1,124,318